Besides Human Mixtard, the phase-out could impact its top brands in the Rs 5,000 crore insulin market including Actrapid, Insulatard, Insulin Detemir and Levemir and Xultophy — marketed mostly ...

Denmark-based global pharma major, Novo Nordisk is now phasing out its Human Mixtard penfill by the year end. However Mixtard in India will continue to be available in vials. Along with it, other form ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should ...

Insulin detemir availability may be of particular concern for pregnant patients, for whom detemir was – until recently – recommended as safer (the only FDA pregnancy category B insulin) than ...

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year.

For example, insulin detemir (Levemir, Novo Nordisk), which is set to be phased out in 2024, has a more pronounced peak than other basal insulins and in some cases requires twice-daily dosing due ...

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage.

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.

The Association of Diabetes Care & Education Specialists (ADCES) says Levemir is the only Insulin Detemir product in the United States. Insulin Detemir is a long-acting type of insulin. There are two ...